HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$0.11
−7.20%Margins
Gross margin
10.3%
EBITDA margin
-6.8%
EBIT margin
-7.4%
Net margin
-8.5%
FCF margin
-5.9%
-11.9%
Return on equity
-8.8%
Return on assets
-9.2%
Return on invested capital
1.20x
Asset turnover
-$751.6K
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026